✦ LIBER ✦

Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi

✍ Scribed by Gilbert M. Burnham

Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 701 KB
Volume: 87
Category: Article
ISSN: 0035-9203
DOI: 10.1016/0035-9203(93)90144-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A placebo-controlled double-blind trial

A placebo-controlled double-blind trial for the treatment of Bancroftian filariasis with ivermectin or diethylcarbamazine

✍ M. Sabry; H. Gamal; N. El-Masry; M.E. Kilpatrick 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Pregabalin for the treatment of fibromya

Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial

✍ Leslie J. Crofford; Michael C. Rowbotham; Philip J. Mease; I. Jon Russell; Rober 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

A community trial of ivermectin for onch

A community trial of ivermectin for onchocerciasis in Sierra Leone: adverse reactions after the first five treatment rounds

✍ J.A.G. Whitworth; D. Morgan; G.H. Maude; M.D. Downham; D.W. Taylor 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 643 KB

Six-month results of a double-blind, pla

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

✍ J. Brandt; A. Khariouzov; J. Listing; H. Haibel; H. Sörensen; L. Grassnickel; M. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Objective There is increasing evidence that tumor necrosis factor α (TNFα) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. This study was designed to investigate the efficacy of anti‐TNFα therapy with etanercept, a 75‐kd recepto

Adalimumab for the treatment of patients

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

✍ Philip J. Mease; Dafna D. Gladman; Christopher T. Ritchlin; Eric M. Ruderman; Se 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Randomised, double-blind, placebo-contro

Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia

✍ Susan H. Fox; Mark Kellett; A. Peter Moore; Alan R. Crossman; Jonathan M. Brotch 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

## Abstract Cannabis may have medicinal uses in a variety of diseases. The neural mechanisms underlying dystonia involve abnormalities within the basal ganglia—in particular, overactivity of the lateral globus pallidus (GPl). Cannabinoid receptors are located presynaptically on GABA terminals withi